PISCATAWAY, N.J., Feb. 19 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. , the recognized leader in painless computer-controlled injection technologies, today announced that it will be exhibiting at the upcoming Chicago Dental Society's 145th Midwinter Meeting.
The STA Single Tooth Anesthesia System(TM) takes the guesswork out of the administration of anesthetic by providing real-time visual and audible feedback via Milestone's patented CompuFlo(R) with DPS(TM) technology. During an injection with the STA System, CompuFlo with DPS continuously monitors the exit pressure of the anesthetic in real-time during all phases of administration. In addition to its general use for all dental injections, the STA System is uniquely capable of predictably and more comfortably administering "Single Tooth Anesthesia" into the Periodontal Intraligamentary (PDL) space, something never before possible using conventional techniques. This injection results in the patient having no collateral numbness and no pain along with instant, predictable anesthesia. The benefits of administering injections with the award-winning STA instrument are significant for the patient, the dentist and the business of dentistry.
About the Chicago Dental Society
The Chicago Dental Society was organized in 1864 and incorporated in 1878. The objective of the Chicago Dental Society is to encourage the improvement of the health of the public, to promote the art and science of dentistry and to represent the interest of the members of the profession and the public that it serves. CDS memberships cover Cook, Lake and DuPage counties and includes approximately 4,100 members. For more information about the CDS, visit http://www.cds.org/.
Safe Harbor Statement
This press release contains forward-looking statements regarding the timing and financial impact of Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report for the year ended December 31, 2008. The forward-looking statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
CONTACT: Dodi Handy, President and CEO, Twitter: @dodihandy, or Media,
Kathy Addison, Director, +1-407-585-1080, mlss@efcg.net, Twitter:
@kathyaddison, both of Elite Financial Communications Group, LLC, for
Milestone Scientific Inc.
Web site: http://www.milesci.com/
http://www.cds.org/
